Arrowhead Pharmaceuticals Inc
(MEX:ARWR)
MXN
586
0 (0%)
Market Cap: 51.46 Bil
Enterprise Value: 45.09 Bil
PE Ratio: 0
PB Ratio: 7.54
GF Score: 51/100 
Arrowhead Pharmaceuticals Inc at Bank of America Merrill Lynch Health Care Conference Transcript
May 15, 2019 / 03:40PM GMT
Unidentified Analyst
Thank you so much for coming today for the Bank of America Healthcare Conference in Vegas. My name is [Chan Wong] and I'm on the large-cap biotech team from [Yin Kwong]. So today, it's my pleasure to have Dr. Chris Anzalone, the President and CEO from Arrowhead. So thank you for coming.
Christopher R. Anzalone
Arrowhead Pharmaceuticals, Inc. - CEO, President & Director
Thank you very much for having us. It's great to be here.
Unidentified Analyst
Yes. Hopefully, you're enjoying the conference so far.
Christopher R. Anzalone
Arrowhead Pharmaceuticals, Inc. - CEO, President & Director
Yes.
Unidentified Analyst
Maybe we just start the Q&A now.
Questions & Answers
Unidentified Analyst;
So you guys have made a lot of progress for the last 1.5 years. Would you mind -- just give us like overall views where your programs are, that will be helpful for our view here.
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers